- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
PAREXEL Introduces Integrated Medical Writing Solutions Service Offering
PAREXEL International Corporation introduced PAREXEL's Medical Writing Solutions, a new offering that provides several communication services needed throughout each critical stage of the drug development and commercialization process.
The medical writing solutions team is made up of hundreds of trained experts that develop high quality documents which are compliant with the latest regulations and guidelines in order to drive value for clients.
The offering is currently available as both functional service projects or as part of larger strategic partnerships based on their study needs. For more information visit http://www.parexel.com/medicalwriting.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
